ERBB4 and melanoma: STAT3 is a critical point of convergence downstream of several hyperactive tyrosine kinase receptors that are either mutated or amplified in melanoma, such as KIT, ERBB4, EPH, FGFR, EGFR and PDGRFA, among others [58].